Publicacions
-
Grañe-Boladeras N, Williams D, Tarmakova Z, Stevanovic K, Villani LA, Mehrabi P, Siu KWM, Pastor-Anglada M and Coe IR.
Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.
FASEB JOURNAL . 33(3): 3841-3850. Nº de cites: 10
-
Pastor-Anglada M, Urtasun N and Perez-Torras S.
Intestinal Nucleoside Transporters: Function, Expression, and Regulation.
COMPREHENSIVE PHYSIOLOGY . 8(3): 1003-1017. Nº de cites: 35
-
Pastor-Anglada M and Perez-Torras S.
Who Is Who in Adenosine Transport.
FRONTIERS IN PHARMACOLOGY . 9: 627-627. Nº de cites: 80
-
Pastor-Anglada M and Perez-Torras S.
Emerging Roles of Nucleoside Transporters.
FRONTIERS IN PHARMACOLOGY . 9: 606-606. Nº de cites: 107
-
Urtasun N, Boces-Pascual C, Boix L, Bruix J, Pastor-Anglada M and Perez-Torras S.
Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.
Oncotarget . 8(52): 90185-90196. Nº de cites: 7
-
Arimany-Nardi C, Claudio-Montero A, Viel-Oliva A, Schmidtke P, Estarellas C, Barril X, Bidon-Chanal A and Pastor-Anglada M.
Identification and Characterization of a Secondary Sodium-Binding Site and the Main Selectivity Determinants in the Human Concentrative Nucleoside Transporter 3.
MOLECULAR PHARMACEUTICS . 14(6): 1980-1987. Nº de cites: 12
-
Minuesa G, Albert C, Pastor-Anglada M, Martinez-Picado J and Koepsell H.
Response to Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1.
J PHARMACOL EXP THER . 360(2): 343-345. Nº de cites: 5
-
Grañé-Boladeras N, Spring CM, Hanna WJ, Pastor-Anglada M and Coe IR.
Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.
CELLULAR AND MOLECULAR LIFE SCIENCES . 73(23): 4559-4575. Nº de cites: 14
-
Grañé-Boladeras N, Perez-Torras S, Lozano JJ, Romero MR, Mazo A, Marín JJ and Pastor-Anglada M.
Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.
PHARMACOLOGICAL RESEARCH . 113(Pt A): 364-375. Nº de cites: 4
-
Minuesa G, Arimany-Nardi C, Erkizia I, Cedeño S, Moltó J, Clotet B, Pastor-Anglada M and Martinez-Picado J.
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(10): 2782-2792. Nº de cites: 18